Veru, Inc. (VERU)
3.15
+0.15
(+5.00%)
USD |
NASDAQ |
Jun 09, 16:00
3.01
-0.14
(-4.44%)
After-Hours: 20:00
Veru SG&A Expense (Quarterly) : 4.073M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Assertio Holdings, Inc. | 11.14M |
| Johnson & Johnson | 6.034B |
| Eli Lilly & Co. | 2.934B |